5,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators

US9102686B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9102686-B2
Application numberUS-201414212808-A
CountryUS
Kind codeB2
Filing dateMar 14, 2014
Priority dateMar 14, 2013
Publication dateAug 11, 2015
Grant dateAug 11, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to a compound of Formula (I): The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.

First claim

Opening claim text (preview).

What is claimed: 1. A compound of formula I or an enantiomer or diastereomer thereof; or a pharmaceutically acceptable salt thereof; wherein: n is 1; X is CH 2 ; R 1 is phenyl or pyridinyl, wherein the phenyl or pyridinyl is optionally substituted with halogen or alkyl; and R 2 is phenyl, pyridinyl, pyrazinyl, pyrimi…

Assignees

Inventors

Classifications

  • Chemistry & Metallurgy · mapped topic

  • C07D471/18Primary

    Chemistry & Metallurgy · mapped topic

  • Chemistry & Metallurgy · mapped topic

  • C07D498/18Primary

    Chemistry & Metallurgy · mapped topic

  • Human Necessities · mapped topic

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9102686B2 cover?
The present invention is directed to a compound of Formula (I): The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.
Who is the assignee on this patent?
Janssen Pharmaceutica Nv
What technology area does this patent fall under?
Primary CPC classification C07D471/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).